Patient perspectives of an integrated program of medical care and substance use treatment

AIDS Patient Care and STDs

Volumn 28, Issue 2, 2014, Pages 71-81

  Drainoni, Mari Lynn ^a,b,c   Farrell, Caitlin ^a   Sorensen Alawad, Amy ^b   Palmisano, Joseph N ^a   Chaisson, Christine ^a   Walley, Alexander Y ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BUPRENORPHINE; COUNSELING; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; FOCUS GROUPS; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; NALOXONE; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT SATISFACTION; PRIMARY HEALTH CARE; PROGRAM EVALUATION; QUALITATIVE RESEARCH; QUALITY OF LIFE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84894175056     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2013.0179     Document Type: Article

References (65)

1. Stein MD. Medical consequences of substance abuse. Psychiat Clinics North Am 1999;22:351-370. (Pubitemid 29275803)
2. Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Int Med 1993;119:1017-1028. (Pubitemid 23334659)
3. Haverkos HW, Lange RW. (1990). Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis 1990;161:894-902. (Pubitemid 20148320)
4. Rajasingham R, Mimiaga MJ, White JM, et al. A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine. AIDS Patient Care STDs 2012;26:36-52.
5. McGeary KA, French MT. Illicit drug use and emergency room utilization. Health Serv Res 2000;35:153-169. (Pubitemid 30213020)
6. Cherpital CJ. Changes in substance use associated with emergency room and primary care services utilization in the United States general population: 1995-2000. Am J Drug Alcohol Abuse 2003;29:789-802.
7. French MT, McGeary KA, Chitwood DD, et al. Chronic illicit drug use, health services utilization and the cost of medical care. Soc Sci Med 2000;50:1703-1713. (Pubitemid 30155500)
8. Stein MD, O'Sullivan PS, Ellis P, et al. Utilization of medical services by drug abusers in detoxification. J Substance Abuse 1993;5:187-193.
9. Walley AY, Paasche-Orlow M, Lee EC, et al. Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. J Addiction Med 2012;6:50-56.
10. Kim TW, Saitz R, Cheng DM, et al. Initiation and engagement in chronic disease management care for substance dependence. Drug Alcohol Depend 2011;115:80-86.
11. Friedmann PD, Alexander JA, D'Anno TA. Organizational correlates of access to primary care and mental health services in drug abuse treatment services. J Substance Abuse Treat 1999;16:71-80. (Pubitemid 29021887)
12. Umbricht-Schneiter A, Ginn DH, Pabst KM, et al. Providing medical care to methadone clinic patients: Referral vs. onsite care. Am J Public Health 1994;84:207-210. (Pubitemid 24138452)
13. Friedmann PD, Hendrickson JC, Gerstein DR, et al. Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care 2006;44:8-15. (Pubitemid 43755474)
14. Institute of Medicine (US) Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders. Improving the Quality of Health Care for Mental and Substance-Use Conditions: Quality Chasm Series. Washington (DC): National Academies Press (US). 2012; http://www.ncbi.nlm.nih. gov/books/NBK19830/. Accessed March 4, 2013.
15. Humphreys K, McLellan AT. A policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients. Addiction 2011;106:2058-2066.
16. Bachman S, Drainoni M, Tobias C. Medicaid managed care, substance abuse treatment and people with disabilities: Review of the literature. Health Social Work 2004;29:189-196. (Pubitemid 39214767)
17. Smith LR, Fisher JD, Cunningham CO, et al. Understanding the behavioral determinants of retention in HIV care: A qualitative evaluation of a situated information, motivation, behavioral skills model of care initiation and maintenance. AIDS Patient Care STDs 2012;26:344-355.
18. Sohler NL, Wong MD, Cunningham WE, et al. Type and pattern of illicit drug use and access to health care services for HIV-infected people. AIDS Patient Care STDs 2007;21:S68-S76.
19. Power R, Koopman C, Volk J, et al. Social support, substance use and denial in relationship to antiretroviral treatment adherence among HIV-infected persons. AIDS Patient Care STDs 2007;17:245-252.
20. Samet JH, Horton N, Traphagen E, et al. Alcohol consumption and HIV disease progression: Are they related? Alcoholism Clin Exp Res 2003;27:862-867. (Pubitemid 36583370)
21. Tobias CR, Cunningham WE, Cabral H, et al. Living with HIV but without medical care: Barriers to engagement. AIDS Patient Care STDs 2007;21:426-434. (Pubitemid 46988408)
22. Wall TL, Sorensen JL, Batki SL, et al. Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Drug Alcohol Dependence 1995;37:261-269.
23. Rosen MI, Black AC, Arnsten JH, et al; MACH14 Study Group. ART adherence changes among patients in community substance use treatment: A preliminary analysis from MACH14. AIDS Res Ther 2012;9:30.
24. Masson CL, Sorensen JL, Phibbs CS, et al. Predictors of medical service utilization among individuals with cooccurring HIV infection and substance abuse disorders. AIDS Care 2004;16:744-755. (Pubitemid 39158987)
25. Laine C, Hauck WW, Gourevitch MN, Rothman J, Cohen AJ, Turner BJ. Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. J Am Med Assoc 2001;285:2355-2362. (Pubitemid 32424104)
26. Schwarz R, Zelenev A, Bruce LD, et al. Retention on buprenorphine treatment reduces emergency department utilization, but no hospitalization, among treatment-seeking patients with opioid dependence. J Substance Abuse Treat 2012;43:451-457.
27. Friedmann PD, Zhang Z, Hendrickson JC, et al. Effect of primary medical care on addiction and medical severity in substance abuse treatment programs. J Gen Int Med 2003;18:1-8. (Pubitemid 36114958)
28. Stenbacka M, Leifman A, Romelsjo A. The impact of methadone on consumption of inpatient care and mortality, with special reference to HIV status. Substance Use Misuse 1998;33:2819-2834. (Pubitemid 28566537)
29. Laine C, Lin YT, Hauck WW, Turner BJ. Availability of medical care services in drug treatment clinics associated with lower repeated emergency department use. Med Care 2005;43:985-995. (Pubitemid 41442464)
30. Stein MD, Anderson B. Injection frequency mediates health service use among persons with a history of drug injection. Drug Alcohol Depend 2003;70:159-168. (Pubitemid 37034168)
31. Andersen R, Bozzette S, Shapiro M, et al. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. Health Services Res 2000;35:389-416. (Pubitemid 30396962)
32. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States. JAMA 1999;281:2305-2315.
33. Cunningham CO, Sohler NL, Cooperman NA, et al. Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV infected drug users. Substance Use Misuse 2011;46 218-232.
34. Cunningham CO, Sohler NL, Wong MD, et al. Utilization of health care services in hard-to-reach marginalized HIV-infected individuals. AIDS Patient Care STDs 2007;21:177-186. (Pubitemid 46608548)
35. Sohler NL, Wong MD, Cunningham WE, et al. Type and pattern of illicit drug use and access to health care services for HIV-infected people. AIDS Patient Care STDs 2007;21:S68-S76.
36. Cunningham WE, Sohler NL, Tobias C, et al. Health services utilization for people with HIV infection: Comparison of a population targeted for outreach with the US population in care. Med Care 2006;44:1038-1047. (Pubitemid 44674036)
37. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. Rockville, MD: Substance Abuse and Mental Health Services Administration, p. 84. http://www.samhsa.gov/ data/NSDUH/2k11Results/NSDUHresults2011.pdf. 2012. Accessed February 25, 2013.
38. Rockett IR, Putnam SL, Jia H, et al. Unmet substance abuse treatment need, health services utilization, and cost: A population-based emergency department study. Ann Emer Med 2005;45:118-127.
39. Dunn CW, Ries R. Linking substance abuse services with general medical care: Integrated, brief interventions with hospitalized patients. Am J Drug Alcohol Abuse 1997;23:1-13. (Pubitemid 27087582)
40. McKay JR. Continuing care research: What we have learned and where we are going. J Substance Abuse Treat 2009;36:131-145.
41. Rockett IR, Putnam SL, Jia H, et al. Unmet substance abuse treatment need, health services utilization, and cost: A population-based emergency department study. Ann Emer Med 2005;45:118-127.
42. Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatr 2001;58:729-736. (Pubitemid 32717796)
43. Parthasarathy S, Mertens J, Moore C, et al. Utilization and cost impact of integrating substance abuse treatment and primary care. Med Care 2003;41:357-367.
44. Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services. Arch Int Med 2001;161:85-91.
45. Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment. JAMA 2001;286:1715-1723.
46. Batki SL, Sorensen JL. Care of injection drug users with HIV. HIV InSite Knowledge Base Chapter. 1998. Retrieved from http://hivinsite.ucsf.edu/InSite. jsp?page=kb-03&doc=kb-03-03-06.
47. McLellan TA, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness. JAMA 2000;284:1689-1695.
48. Azzone V, Frank RG, Normand S, Burnam MA. Effect of insurance parity on substance abuse treatment. Psychiatr Serv 2011;62:129-134.
49. United States Department of Labor. The mental health parity and addiction equity act of 2008. Retrieved October 10, 2010, from http://www.dol.gov/ebsa/ newsroom/fsmhpaea.html.
50. Walley AY, Tetrault JM, Friedmann PD. Integration of substance use treatment and medical care: A special issue of JSAT. J Substance Abuse Treat 2012;43:377-381.
51. Padwa H, Urada D, Antonini VP, Ober A, Crevecoeur-MacPhail DA, Rawson RA. Integrating substance use disorder services with primary care: The experience in California. J Psychoactive Drugs 2012;44:299-306.
52. Fiellin DA, Pantalon MV, Chawarski MC, Moore VA, Sullivan LE, O'Connor PG, Schottenfeld RS. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. New Eng J M 2006;355:365-374. (Pubitemid 44127539)
53. Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative Research. Piscataway, New Jersey: Aldine Publishing; 1967
54. Rich E, Lipson D, Libersky J, Parchman M. Coordinating Care for Adults With Complex Care Needs in the Patient-Centered Medical Home: Challenges and Solutions. 2012 White Paper (Prepared by Mathematica Policy Research under Contract No. HHSA290200900019I/HHSA29032005T). AHRQ Publication No. 12-0010-EF. Rockville, MD: Agency for Healthcare Research and Quality. http://pcmh.ahrq.gov/ portal/server.pt/community/pcmh-home/1483/PCMH-Home-Papers% 20Briefs%20and%20Othe%20Resources-v2. Accessed February 22, 2013.
55. Larson EB, Reid R. The patient-centered medical home movement: Why now? JAMA 2010;303:1644-1645.
56. Magnus M, Schmidt N, Kirkhart K, Schieffelin C, Fuchs N, Brown B, Kissinger PJ. Association between ancillary services and clinical and behavioral outcomes among HIV-infected women. AIDS Patient Care STDs 2001;15:137-145. (Pubitemid 32246774)
57. Thompson AS, Blankenship KM, Selwyn PA, et al. Evaluation of an innovative program to address the health and social service needs of drug-using women with or at risk for HIV infection. J Commun Health 1998;23:419-440. (Pubitemid 28510066)
58. Rajabiun S, Mallinson RK, McCoy K, et al. "Getting me back on track": The role of outreach interventions in engaging and retaining people living with HIV/AIDS in medical care. AIDS Patient Care STDs 2007;21:S20-S29.
59. Health Resources and Services Administration. 2012. Part A: Grants to Emerging Metropolitan and Transitional Grant Areas. http://hab.hrsa.gov/ abouthab/parta.html. Accessed February 22, 2013.
60. Weiss L, Egan JE, Botsko M, et al. The BHIVES collaborative: Organization and evaluation of a multisite demonstration of integrated buprenorphine/ naloxone and HIV treatment. J Acq Immune Def Syndromes 2011;56:S7-S13.
61. Lucas GM, Chaudhry A, Hsu J, et al. Clinic based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial. Ann Int Med 2010;152:704-711.
62. Weiss L, Netherland J, Egan JE, et al. Integration of buprenorphine/naloxone treatment into HIV clinical care: Lessons from the BHIVES collaborative. J Acq Immune Def Syndromes 2011;56:S68-S75.
63. Sullivan LE, Tetrault J, Bangalore D, et al. Training HIV physicians to prescribe buprenorphine for opioid dependence. Substance Abuse 2006;27:13-18. (Pubitemid 44800477)
64. Rebholz C, Drainoni M, Cabral, H. (2009). Substance use and social stability among at-risk HIV-infected persons. J Drug Issues 2009;30:851-870.
65. Yarnall KSH, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: Is there enough time for prevention? Am J Public Health 2003;93:635-641. (Pubitemid 36790885)